Medtronic plc. (NYSE:MDT) EVP Bryan C. Hanson sold 16,000 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $82.82, for a total transaction of $1,325,120.00. Following the transaction, the executive vice president now owns 88,818 shares in the company, valued at $7,355,906.76. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Bryan C. Hanson also recently made the following trade(s):

  • On Thursday, November 16th, Bryan C. Hanson sold 16,000 shares of Medtronic stock. The stock was sold at an average price of $79.02, for a total transaction of $1,264,320.00.

Medtronic plc. (NYSE MDT) traded down $0.07 during midday trading on Monday, reaching $83.43. 5,204,169 shares of the company’s stock were exchanged, compared to its average volume of 4,972,112. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50. The company has a market cap of $113,017.09, a P/E ratio of 18.00, a P/E/G ratio of 2.30 and a beta of 1.00. Medtronic plc. has a 52-week low of $69.35 and a 52-week high of $89.72.

Medtronic (NYSE:MDT) last posted its quarterly earnings data on Tuesday, November 21st. The medical technology company reported $1.07 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.99 by $0.08. The firm had revenue of $7.05 billion during the quarter, compared to the consensus estimate of $7.05 billion. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The business’s revenue for the quarter was down 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.12 EPS. research analysts forecast that Medtronic plc. will post 4.77 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 19th. Shareholders of record on Friday, December 29th will be issued a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date of this dividend is Thursday, December 28th. Medtronic’s dividend payout ratio is currently 50.41%.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Hudock Capital Group LLC lifted its holdings in shares of Medtronic by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 2,195 shares of the medical technology company’s stock worth $194,000 after acquiring an additional 11 shares during the period. Triangle Securities Wealth Management lifted its holdings in shares of Medtronic by 0.3% during the 2nd quarter. Triangle Securities Wealth Management now owns 4,396 shares of the medical technology company’s stock worth $390,000 after acquiring an additional 15 shares during the period. IFC Holdings Incorporated FL lifted its holdings in shares of Medtronic by 0.3% during the 2nd quarter. IFC Holdings Incorporated FL now owns 5,673 shares of the medical technology company’s stock worth $501,000 after acquiring an additional 17 shares during the period. Arcus Capital Partners LLC lifted its holdings in shares of Medtronic by 0.8% during the 2nd quarter. Arcus Capital Partners LLC now owns 3,249 shares of the medical technology company’s stock worth $288,000 after acquiring an additional 25 shares during the period. Finally, Guardian Life Insurance Co. of America lifted its holdings in shares of Medtronic by 0.6% during the 1st quarter. Guardian Life Insurance Co. of America now owns 5,288 shares of the medical technology company’s stock worth $426,000 after acquiring an additional 29 shares during the period. 81.86% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts recently commented on the stock. Cowen set a $95.00 price target on shares of Medtronic and gave the company a “buy” rating in a research note on Tuesday, August 22nd. Oppenheimer reiterated a “buy” rating and issued a $92.00 price target on shares of Medtronic in a research note on Tuesday, August 22nd. Royal Bank of Canada reiterated a “buy” rating and issued a $90.00 price target on shares of Medtronic in a research note on Monday, August 21st. Stifel Nicolaus upped their price target on shares of Medtronic from $83.00 to $85.00 and gave the company a “hold” rating in a research note on Wednesday, November 22nd. Finally, Northland Securities reiterated a “hold” rating and issued a $80.00 price target on shares of Medtronic in a research note on Wednesday, November 22nd. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and fourteen have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $88.57.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/medtronic-plc-mdt-evp-sells-1325120-00-in-stock/1771802.html.

About Medtronic

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Insider Buying and Selling by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.